SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-004103
Filing Date
2014-08-12
Accepted
2014-08-12 17:26:35
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 424487
2 CERTIFICATION sbfm_ex311.htm EX-31.1 14811
3 CERTIFICATION sbfm_ex312.htm EX-31.2 14623
4 CERTIFICATION sbfm_ex32.htm EX-32 6515
5 img001.jpg GRAPHIC 17106
6 img002.jpg GRAPHIC 21184
7 img003jpg.jpg GRAPHIC 15066
8 img004.jpg GRAPHIC 12569
  Complete submission text file 0001354488-14-004103.txt   1240810

Data Files

Seq Description Document Type Size
9 sbfm-20140630.xml EX-101.INS 42250
10 sbfm-20140630.xsd EX-101.SCH 10384
11 sbfm-20140630_cal.xml EX-101.CAL 23624
12 sbfm-20140630_def.xml EX-101.DEF 6342
13 sbfm-20140630_lab.xml EX-101.LAB 76924
14 sbfm-20140630_pre.xml EX-101.PRE 54711
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 141035082
SIC: 8742 Services-Management Consulting Services